(News Bulletin 247) – BIOCORP announces today the signing of a contract with the pharmaceutical company HRA Pharma, a subsidiary of the world leader in self-medication products Perrigo company.
This agreement covers the development and industrialization of an innovative medical device aimed at instantly relieving the patient and accelerating the healing of skin lesions.
The two parties have entered into an initial development agreement to design, test and validate a device in compliance with the requirements of the MDR (Medical Device Regulation) and the FDA (Food and Drug Administration).
BIOCORP will ensure the industrialization of this new device and the qualification of the manufacturing, filling and packaging services within its factory in Issoire.
Under the terms of this exclusive agreement, BIOCORP will receive an initial milestone payment this year, followed by further payments based on progress from 2024.
Eric Dessertenne, Managing Director of BIOCORP, said: ‘We are very proud that HRA Pharma, supplier of a world famous brand of dressings, has chosen us for the development of a new innovation.’
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
